Moderna’s (MRNA) Stock Falls on Omicron Variant Concerns

Moderna (MRNA) shares decline following a two-day rise as the Omicron-variant creates uncertainty with limited data. The next couple of weeks may provide a clearer picture.

Leave a comment

Your email address will not be published. Required fields are marked *